These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 31825388)

  • 1. [Social cognition impairments in Parkinson's disease].
    Lyashenko EA; Iakovleva OV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(9. Vyp. 2):37-43. PubMed ID: 31825388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emotional and cognitive social processes are impaired in Parkinson's disease and are related to behavioral disorders.
    Narme P; Mouras H; Roussel M; Duru C; Krystkowiak P; Godefroy O
    Neuropsychology; 2013 Mar; 27(2):182-92. PubMed ID: 23527646
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Impairment of social cognition in Parkinson's disease].
    Yoshimura N; Kawamura M
    No To Shinkei; 2005 Feb; 57(2):107-13. PubMed ID: 15856756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Everyday functioning of people with Parkinson's disease and impairments in executive function: a qualitative investigation.
    Kudlicka A; Hindle JV; Spencer LE; Clare L
    Disabil Rehabil; 2018 Oct; 40(20):2351-2363. PubMed ID: 28597694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cognitive and behavioral disorders in Parkinson's disease: an update. I: cognitive impairments.
    Papagno C; Trojano L
    Neurol Sci; 2018 Feb; 39(2):215-223. PubMed ID: 29043468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonmotor Symptoms in Parkinson Disease: A Descriptive Review on Social Cognition Ability.
    Palmeri R; Lo Buono V; Corallo F; Foti M; Di Lorenzo G; Bramanti P; Marino S
    J Geriatr Psychiatry Neurol; 2017 Mar; 30(2):109-121. PubMed ID: 28073327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impaired decision-making in Parkinson's disease.
    Mimura M; Oeda R; Kawamura M
    Parkinsonism Relat Disord; 2006 Apr; 12(3):169-75. PubMed ID: 16563850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of the cognitive and behavioral sequelae of Parkinson's disease: relationship to frontostriatal circuitry.
    Zgaljardic DJ; Borod JC; Foldi NS; Mattis P
    Cogn Behav Neurol; 2003 Dec; 16(4):193-210. PubMed ID: 14665819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Affective and cognitive Theory of Mind in patients with parkinson's disease.
    Bodden ME; Mollenhauer B; Trenkwalder C; Cabanel N; Eggert KM; Unger MM; Oertel WH; Kessler J; Dodel R; Kalbe E
    Parkinsonism Relat Disord; 2010 Aug; 16(7):466-70. PubMed ID: 20538499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vivo cholinergic basal forebrain atrophy predicts cognitive decline in de novo Parkinson's disease.
    Ray NJ; Bradburn S; Murgatroyd C; Toseeb U; Mir P; Kountouriotis GK; Teipel SJ; Grothe MJ
    Brain; 2018 Jan; 141(1):165-176. PubMed ID: 29228203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. White matter degeneration profile in the cognitive cortico-subcortical tracts in Parkinson's disease.
    Hanganu A; Houde JC; Fonov VS; Degroot C; Mejia-Constain B; Lafontaine AL; Soland V; Chouinard S; Collins LD; Descoteaux M; Monchi O
    Mov Disord; 2018 Jul; 33(7):1139-1150. PubMed ID: 29683523
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropsychiatric Issues in Parkinson's Disease.
    Cooney JW; Stacy M
    Curr Neurol Neurosci Rep; 2016 May; 16(5):49. PubMed ID: 27048443
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vascular contribution to dementia in Parkinson's disease.
    Korczyn AD
    Neurodegener Dis; 2010; 7(1-3):127-30. PubMed ID: 20173342
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The moral brain and moral behaviour in patients with Parkinson's disease: a review of the literature.
    Santens P; Vanschoenbeek G; Miatton M; De Letter M
    Acta Neurol Belg; 2018 Sep; 118(3):387-393. PubMed ID: 30014443
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Theory of Mind in Parkinson's disease.
    Freedman M; Stuss DT
    J Neurol Sci; 2011 Nov; 310(1-2):225-7. PubMed ID: 21705020
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathophysiology of Parkinson's disease behavior--a view from the network.
    Caviness JN
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S39-43. PubMed ID: 24262185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Theory of mind performance in Parkinson's disease is associated with motor and cognitive functions, but not with symptom lateralization.
    Nobis L; Schindlbeck K; Ehlen F; Tiedt H; Rewitzer C; Duits AA; Klostermann F
    J Neural Transm (Vienna); 2017 Sep; 124(9):1067-1072. PubMed ID: 28584926
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cognitive impairment in Parkinson's disease.
    Girotti F; Marano R; Grazzi L; Scigliano G; Caraceni T
    J Neural Transm Suppl; 1986; 22():163-70. PubMed ID: 3465870
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Voxel-Based Morphometry and Social Cognitive Function in Parkinson's Disease].
    Kobayakawa M
    Brain Nerve; 2017 Nov; 69(11):1323-1329. PubMed ID: 29172197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.